Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

AMRI boosts opiate API biz through tech transfer and supply deal with Saneca

AMRI has inked a deal with Slovakia’s Saneca Pharmaceuticals to bolster its opium-derived API portfolio.

BMS pays $125m to Promedior in second 'right-to-buy' option in fibrosis space

Bristol-Myers Squibb has acquired the rights to buy immunotherapy firm Promedior and could pay up to $1.25bn (€1.1bn) depending on the clinical development of its lead fibrosis product PRM-151.

Fareva buys Merck & Co API plant in France and outlines plan to invest €25m

Fareva has bought an API plant in France from Merck & Co. and outlined plans to turn it into a high-potency actives site.

Veterans suited to pharma says Texas A&M

Army training is good for a biopharma career according to the US National Center for Therapeutics Manufacturing, which is seeking former military personnel interested in learning about bioprocessing.

Cure not kill: Dynamite ingredient can improve cancer treatment says study

Nitroglycerin could make cancer drugs more effective say researchers trying to use the dynamite ingredient to help destroy tumours.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...